Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03479827 · ClinicalTrials.gov registry record
Measuring the Peripheral Optical Quality of The Eye
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 24
- Enrollment target
NCT03479827: Completed study, sponsored by University of Rochester.
NCT03479827 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03479827 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The goal of the study is to quantify wavefront aberration profiles of the eye with and without contact lens across the visual field. This will enable us to investigate the impact of the aberration on retinal image quality.
Primary Outcome
The scanning wavefront sensor will be used to collect data. Mean Wavefront aberrations for each trail will be analyzed.
Interventions
- DEVICE Monofocal Contact Lens
- DEVICE Bifocal Contact Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2018-08-31 |
| Est. Completion | 2020-11-29 |
What the finished NCT03479827 record still lists
NCT03479827 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Monofocal Contact Lens is the first listed.
NCT03479827 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03479827 about?
NCT03479827 is a clinical study titled "Measuring the Peripheral Optical Quality of The Eye". The goal of the study is to quantify wavefront aberration profiles of the eye with and without contact lens across the visual field. This will enable us to investigate the impact of the aberration on retinal image quality.
What is the current status of trial NCT03479827?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2018-08-31. Estimated completion is 2020-11-29.
What interventions are being tested in trial NCT03479827?
The interventions under investigation include: Monofocal Contact Lens (DEVICE), Bifocal Contact Lens (DEVICE).
Who is sponsoring clinical trial NCT03479827?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI